Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Incyte Corporation
About INCY
Incyte Corporation is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of therapeutics. The Company operates in three therapeutic areas: Hematology, Oncology, and Inflammation and Autoimmunity (IAI). Its hematology franchise includes four approved products, JAKAFI (ruxolitinib), ICLUSIG (ponatinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) and NIKTIMVO (axatilimab-csfr), as well as multiple clinical development programs. Its oncology franchise includes two approved products, PEMAZYRE (pemigatinib) and ZYNYZ (retifanlimab-dlwr), as well as several clinical development programs. Its Inflammation and Autoimmunity franchise is comprised of one approved product, OPZELURA (ruxolitinib) cream, with several clinical programs in development. The Company manages business activities on a consolidated basis through the development and commercialization of oncology and dermatology products.
Market Capitalisation
$21.68B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.49M
High today
$109.64
Low today
$106.53
Open price
$107.83
52-week high
$112.29
52-week low
$66.74
Ready to start your investing journey with Stake?
Open an accountHow do I buy INCY shares in Australia?
Buying INCY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Incyte Corporation in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in INCY
What is the ticker symbol of Incyte Corporation?
The ticker symbol for Incyte Corporation is INCY.
How much is one share of INCY?
One share of INCY is valued at $108.52 as of 14 June 2026.
What is the market capitalisation of Incyte Corporation INCY?
As of 14 June 2026 Incyte Corporation has a market cap of $21.68B.
What is the P/E ratio of INCY?
The Price to Earnings ratio of INCY is 15.25.
What is the Earnings Per Share of INCY?
The Earnings Per Share of INCY is $7.07.
What is the 52-week high for Incyte Corporation stock?
The Incyte Corporation 52-week high stock price is $112.29.
What is the 52-week low for Incyte Corporation stock?
The Incyte Corporation 52-week low stock price is $66.74.
Can I buy INCY shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy INCY shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in INCY on Stake
- Buy INCY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of INCY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
INCY related stocks